3 ms·
Drugs acting on GLP-1 (ozempic), GIP, and glucagon receptors are largely shown to help hearts and cardiovascular health specifically (and independently of weigh
by reaperman 3y ago
Drugs acting on GLP-1 (ozempic), GIP, and glucagon receptors are largely shown to help hearts and cardiovascular health specifically (and independently of weight loss). They also improve lipid profiles (HDL/LDL), and have a multitude of other benefits.
Whether they, for example, increase the rate of glial brain cancer ... they really haven't been out long enough to know.